60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) Short Interest Update

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) was the recipient of a significant growth in short interest in August. As of August 31st, there was short interest totaling 1,930 shares, a growth of 130.0% from the August 15th total of 839 shares. Based on an average trading volume of 4,166 shares, the days-to-cover ratio is currently 0.5 days.

60 Degrees Pharmaceuticals Stock Performance

Shares of NASDAQ SXTPW opened at $0.03 on Monday. The company has a 50 day moving average of $0.03 and a 200 day moving average of $0.04. 60 Degrees Pharmaceuticals has a twelve month low of $0.02 and a twelve month high of $0.15.

60 Degrees Pharmaceuticals Company Profile

60 Degrees Pharmaceuticals, Inc operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue.